The Life Science Feed
Deep dives with clinicians, researchers, and industry leaders.
All episodes
Biomarkers and Novel Treatments Highlight Prostate Cancer Advances at ASCO
New research presented at ASCO 2025 details advances in prostate cancer, including prognostic biomarkers and precision therapies for advanced disease.
Lung NeoplasmsHalf of Older Adults With Metastatic Lung Cancer Receive No Systemic Treatment
A significant proportion of older adults diagnosed with metastatic non-small cell lung cancer receive no systemic treatment, highlighting a critical care gap.
Prostatic NeoplasmsAlpha-Emitting Radioantibody Lowers PSA in CRPC
An investigational alpha-emitting radioantibody demonstrated a reduction in PSA levels in patients with castration-resistant prostate cancer (CRPC).
Giredestrant Improves Breast Cancer Survival Regardless of Menopause
8 min readBowhead Whale Longevity Genes Offer Clues for Cancer, Aging
8 min readTucatinib Extends PFS in HER2-Positive Breast Cancer, No New Safety Signals
11 min readWearable Devices Detect CAR-T CRS Hours Earlier, Improving Patient Outcomes
7 min readGenetic Test Identifies Breast Cancer Patients Who May Avoid Chemotherapy
12 min read
Alcohol and Sugar: A Dual Metabolic Challenge for Patients
Patients consuming alcohol and high-sugar diets face a compounded metabolic risk, impacting liver function and glucose regulation. Clinicians must address both factors.
Fatty LiverLiver-Directed Treatment Shows Efficacy in Metabolic Dysfunction
A novel liver-directed treatment presented at endo 2026 offers a targeted approach for metabolic dysfunction, addressing a significant unmet clinical need.
Liver CirrhosisEASL 2026: Liver and Spleen Elastography for Fibrosis Assessment
EASL 2026 will feature a Skills Learning Centre on liver and spleen elastography, highlighting its role in non-invasive fibrosis assessment.
Nearly 1 in 10 With Primary Biliary Cholangitis Have CKD
7 min readEASL 2026: Alcohol Policy Action Needed for Liver Disease
7 min readMetabolic Dysfunction Associated Steatotic Liver Disease: An Overview
5 min readEASL Congress 2026: Key Trials to Watch in Liver Disease Management
7 min read
ESC Cardio-Oncology 2026: Key Sessions and Anticipated Focus Areas
The ESC Cardio-Oncology 2026 congress will address cardiotoxicity from cancer therapies, focusing on early detection and management strategies.
Heart FailureUniversal Heart Failure Definition Issued by Global Societies
Four major cardiology societies released a universal definition of heart failure, aiming to standardise diagnosis and research across the globe.
Congenital Heart Defects5D MRI Halves Scan Time for Congenital Heart Disease Imaging
A novel 5D MRI technique significantly reduces scan duration for congenital heart disease patients, improving image quality and patient experience.
AI-Assisted Fetal Echocardiography Improves Early CHD Detection
8 min readHypotension Linked to Increased Alzheimer's Disease Risk
7 min readVitamin K2 Supplementation May Curb Coronary Calcification
12 min readNovel Therapies Target Atherogenic Lp(a) Particle
11 min readHeat-Attributable CVD Years of Life Lost Projected to Rise Through 2050
8 min readIsaacs Emphasizes 'Human Touch' in Diabetes Care Beyond Technology
Diana Isaacs, PharmD, an ADA award winner, advocates for integrating empathetic, patient-centered approaches with advanced diabetes technology to improve outcomes.
Diabetes Mellitus Type 2GLP-1 Agonists Show Ocular Safety, Potential Therapeutic Role
GLP-1 receptor agonists appear safe for ocular health, with emerging evidence suggesting potential therapeutic benefits for various eye conditions.
Diabetes Mellitus Type 2Elecoglipron Oral GLP-1 Reduces Glucose, Weight in Phase 2
Elecoglipron, an investigational oral GLP-1 receptor agonist, demonstrated reductions in HbA1c and body weight in phase 2 trials.
GLP-1 Receptor Agonist Use Varies Widely for Youth Type 2 Diabetes
8 min readMedically Tailored Meals Cut HbA1c More Than Subsidies in Type 2 Diabetes
11 min readUnapproved Retatrutide Use Challenges Clinicians
10 min readFoundayo Confers Greater HbA1c Reduction Than Farxiga, Ozempic Pill in T2D
8 min readGLP-1 Nonresponders Often Underserved by Inadequate Dosing, Poor Adherence
10 min read
Cognitive Rehabilitation Eases Long-COVID Brain Fog
Cognitive rehabilitation significantly improved brain fog symptoms in patients with long-COVID, offering a structured approach to managing persistent neurological sequelae.
Alzheimer DiseaseCreatine Supplementation: Limited Evidence for Brain Health Benefits
Creatine supplementation shows inconsistent and largely unproven benefits for brain health in healthy adults, with some promise in specific populations facing metabolic stress.
Amyotrophic Lateral SclerosisHuntington's Disease Therapy Faces Regulatory Setbacks, Clinical Impact
A novel investigational therapy for Huntington's disease has encountered significant regulatory hurdles, prompting re-evaluation of its clinical development pathway.
TBI Linked Bidirectionally With Psychiatric and Neurologic Conditions
7 min readMigraine Linked to Increased Vascular Dementia Odds in Observational Data
11 min readEptinezumab Improves Cognitive Symptoms in Migraine Patients
13 min readDopamine Agonists: A Fading Role in Parkinson's Treatment?
9 min readNew Parkinson's Drug Offers Sustained Levodopa Levels
9 min readNew Regimen Confers 'Meaningful' Benefit in Aggressive Lymphoma
7 min readFDA Expands Casgevy for Sickle Cell in Children 2 Years and Older
8 min readMonoclonal Antibodies May Complicate Transfusion Testing
7 min readBlood Transfusion Safety: Pathogen Inactivation Reduces Transfusion-Transmitted Infections
7 min readChemo-Free Therapy Improves Outcomes in Pediatric APL (EHA 2026)
Prostate Care: Balancing Immediate Relief with Long-Term Retreatment
10 min readEASL 2026 Forum: Enhancing Patient-Clinician Communication
Clopidogrel and Omeprazole: Re-evaluating Concomitant Use Risk
GLP-1s for Addiction: Are We There Yet?
10 min readML Model Predicts Epilepsy Onset in Depression, Depression in Epilepsy
Sleep Disruption and Fear Drive Chronic Rheumatic Pain
11 min readPodcast: Why Cheaper Humira Alternatives Face Resistance
ListenPodcast: Stopping Spinal Fusion Or Protecting The Gut?
ListenPodcast: Chasing Absolute Zero In Rheumatoid Arthritis
ListenPodcast: The ORAL Surveillance JAK Inhibitor Controversy
ListenB-Cell Dysregulation Targeted Upstream in Primary Sjögren Disease
7 min readXLH Management: Rheumatology Must Adapt at EULAR 2026
7 min readEGPA: Early Recognition & Targeted Intervention Improve Outcomes
8 min readRA Patients Face Elevated Fracture Risk: EULAR 2026 Highlights
7 min readSalivary Galectin-9 Elevated in Primary Sjögren's, Lacks Disease Activity Correlation
8 min read
Air Embolism: Two Cases After Percutaneous Lung Biopsy
7 min readSingle Question May Flag Poor Quality Sleep in Patients
9 min readPembrolizumab Reduces Pulmonary AEs vs Chemotherapy in NSCLC
8 min readDupilumab Superior to Omalizumab in High-Biomarker Asthma
7 min readATS 2026: NTM Lung Disease Detection, Therapy, QoL Advancements
8 min readBRINSUPRI® First Therapy Approved for NCFB at ATS 2026
7 min readEpithelial Cytokines Link Severe Asthma, CRSwNP, COPD at ATS 2026
8 min readTriple Therapy in Asthma: Real-World Evidence Supports Earlier Use
7 min readYUTREPIA® (treprostinil) Inhalation Powder for PH-ILD Patients
8 min readIPF/PPF: Patient and Pulmonologist Perspectives Highlight Care Gaps
8 min read
COVID Vaccine Efficacy in Children: A Review of Real-World Data
8 min readRifadin Syrup Under Review for Carcinogen Concerns
7 min readPublic Health Measures Significantly Reduced COVID-19 Incidence
8 min readData Integrity Concerns Raised in Pfizer's COVID-19 Vaccine Trial
7 min readVaccine Cold Chain Integrity Underpins Vaccine Security
8 min readCurrent and Emerging Therapies for Pulmonary Tuberculosis
6 min readDRC Ebola Outbreak Exposes Global Health Underfunding Consequences
7 min readEbola Outbreak May Become Deadliest on Record, Agencies Warn
8 min readEbola: Essential Information for Suspected Cases
7 min readThree Vaccines in Development for Bundibugyo Ebola Outbreak
6 min read
CAR T-Cell Therapy Nears Approval for Refractory Skin Diseases
7 min readTSW Controversy: Mitochondrial NAD Excess Identified, Diagnostic Clarity Emerges
9 min readPrior Authorization Delays Atopic Dermatitis Treatment Access
13 min readPatient-Reported Factors Redefine Alopecia Areata Severity
7 min readScalp Lesions: Rare Malignancies Mimic Benign Conditions
7 min readDown Syndrome: Skin Conditions Demand Dermatologists’ Attention
7 min readGLP-1 Receptor Agonists and Psoriatic Disease: A Deep Dive
7 min readGoat Milk Formula Linked With Less Atopic Dermatitis
7 min readParoxetine's Mechanism in Rosacea: Serotonin Pathway Clues
7 min readRemibrutinib Resolves Chronic Inducible Urticaria Symptoms
8 min read
Munich, DEAug 28 – 31UpcomingEASD 2026
Madrid, ESSep 9 – 12UpcomingERS 2026
Copenhagen, DKSep 12 – 15UpcomingESMO 2026Berlin, DESep 12 – 16UpcomingECTRIMS 2026Barcelona, ESSep 17 – 20UpcomingUEG Week 2026
Vienna, ATOct 3 – 7UpcomingAHA 2026
Chicago, USNov 7 – 9UpcomingACR 2026Washington DC, USNov 14 – 19UpcomingASH 2026New Orleans, USDec 12 – 15UpcomingACC.27 Together With WCCHouston, USApr 10 – 12PastENDO 2026Boston, USJun 13 – 16PastEHA 2026
Stockholm, SEJun 11 – 14PastEULAR 2026
London, GBJun 3 – 6PastASCO 2026Chicago, USMay 29 – Jun 2PastEASL 2026Barcelona, ESMay 27 – 30UpcomingESC 2026Munich, DEAug 28 – 31UpcomingEASD 2026Madrid, ESSep 9 – 12UpcomingERS 2026Copenhagen, DKSep 12 – 15UpcomingESMO 2026Berlin, DESep 12 – 16UpcomingECTRIMS 2026Barcelona, ESSep 17 – 20UpcomingUEG Week 2026Vienna, ATOct 3 – 7UpcomingAHA 2026Chicago, USNov 7 – 9UpcomingACR 2026Washington DC, USNov 14 – 19UpcomingASH 2026New Orleans, USDec 12 – 15UpcomingACC.27 Together With WCCHouston, USApr 10 – 12PastENDO 2026Boston, USJun 13 – 16PastEHA 2026Stockholm, SEJun 11 – 14PastEULAR 2026London, GBJun 3 – 6PastASCO 2026Chicago, USMay 29 – Jun 2PastEASL 2026Barcelona, ESMay 27 – 30
Late-Onset Genetic Cholestasis: Underdiagnosis in Adults Examined
DLBCL Treatment: Emerging Targeted Therapies at EHA 2026
AML: Fitness, Not Age, Predicts Intensive Chemotherapy Eligibility
Classic CAH: New Approaches to Glucocorticoid Dosing
DLBCL Treatment Sequencing: EHA 2026 Explores Current Therapies
IKT-001 Adaptive Study Programme for Pulmonary Arterial Hypertension
CLL: EHA 2026 to Address Unmet Needs in Treatment Selection
ILD Diagnosis and Management: A Practical ATS 2026 Update
Myelofibrosis Management: Cytopenia Guides Treatment at EHA 2026
ASCO 2026 May 31st Program Highlights: Focus on Novel Immunotherapies
TLR7/8 Inhibition Offers New Lupus Perspective at EULAR 2026
Personalized Hemophilia Care: EHA 2026 Highlights Individualized Approaches
Multimodal OSA Treatment: Nerve Stimulation, Surgery, Oral Appliances
DLBCL Management: Bispecific Antibodies as Emerging Therapeutic Option
Cancer Care Disparities Highlighted in Crisis, Displaced Populations
Immunotherapy and Targeted Therapy: New Data from ASCO 2026
BCMA Bispecifics Transition to Community Myeloma Care: EHA 2026
Fixed-Duration BCL-2 Combo Offers Time Off Treatment in 1L CLL
Yoga Reduces Insomnia, Fatigue, Anxiety in Cancer Survivors
RA Care: Navigating Treatment Choices at EULAR 2026
Optimising Transplant in Haemoglobinopathies: EHA 2026 Perspectives
ATS 2026: Lung Cancer Management Advances in Targeted Therapy
Novel Biomarkers Improve Pediatric Solid Tumor Detection
Caplacizumab Improves iTTP Outcomes in Real-World Settings
Bispecific Antibodies Show Promise in Relapsed/Refractory Haematological Malignancies
Hypercortisolism: Emerging Diagnostic and Management Insights
CAR T Cell Therapy Shows Efficacy in Autoimmune Diseases at EULAR 2026
Early Intervention Crucial for Inflammatory Joint Disease, Osteoporosis
Chemo-Free Therapy Improves Outcomes in Pediatric APL (EHA 2026)
PEAK Study Shows Novel Agent Improves PFS in Advanced GIST
Treat-to-Target in SLE: Balancing Burden, Benefit, and Risk
CAR T Therapy Shows Sustained Efficacy in Relapsed/Refractory Lymphoma
Next-Gen Extracellular Vesicles: Biomarkers, Targets, Deliverables in Oncology
HYRNUO® (Sevabertinib) Shows Efficacy in Advanced Solid Tumours
AI in Hematology: EHA 2026 Focuses on Practical, Ethical Integration
Korlym® Improves Cushing's Syndrome Symptoms in Patient Experience Data
IDH1m AML: Ivosidenib Plus Azacitidine Improves OS by 12.5 Months
EASL 2026: PSC Therapies Advance Beyond Symptom Management
EASL 2026: Liver and Spleen Elastography for Fibrosis Assessment
Right Heart Catheterization: ATS 2026 Clarifies Waveform Interpretation
Inluriyo™ and Verzenio® Presentations at ASCO 2026
NK Cell Immunotherapy: Biology to Clinic at AACR 2026
ATS 2026: NTM Lung Disease Detection, Therapy, QoL Advancements
HER2-Expressing Breast Cancer: Advancements in Targeted Therapies
Obesity Management Improves Psoriatic Disease Outcomes
CLL First-Line Therapy: Case-Based Insights from EHA 2026
Afirma Molecular Testing: Unique Situations and New Prognostic Development
Oncodetect® MRD Test Shows Analytical Validity, Clinical Utility at ASCO
Salivary Galectin-9 Elevated in Primary Sjögren's, Lacks Disease Activity Correlation
AI, Wearables Transform Sleep Diagnostics: ATS 2026 Preview
Iron Status Clarifies Erythrocytosis, Symptoms in Polycythemia Vera
BRINSUPRI® First Therapy Approved for NCFB at ATS 2026
MCED Tests Show Promise for Earlier Cancer Detection at ASCO 2026
DNA Methylation Patterns Emerge as Sarcoma Biomarkers
Tirzepatide: Efficacy in Weight Management Explored at ATS 2026
Autoantibodies: Hidden Drivers of Autoimmune Rheumatic Diseases
Pediatric Pulmonary Research Gaps Highlighted for Global Health
Novel Approaches in R/R MM: Expert Perspectives from EHA 2026
Defining Hyperphagia Treatment Possibilities in Prader-Willi Syndrome
12 Months of Romosozumab Builds Bone Density in Postmenopausal Osteoporosis
Multidisciplinary Approach Improves Autoimmune ILD Management
Rare Conditions: EHA 2026 Highlights Diagnostic Challenges
SpA Remission: Clinical Symptoms vs. Subclinical Inflammation at EULAR 2026
Bispecific Antibodies Show Promise in Relapsed/Refractory Multiple Myeloma
Bispecific Antibodies Efficacious in Multiple Myeloma with Renal Impairment
Biomarkers and Novel Treatments Highlight Prostate Cancer Advances at ASCO
ITP Management: Bridging Clinician and Patient Perspectives
AI in Oncology: Practical Applications Transforming Cancer Care
Obesity Care: Tailored Treatment Strategies Highlighted at endo 2026
NDMM Treatment Advances: Quadruplet Regimens Show Efficacy
Cancer Elimination at ASCO 2026: Aspirational Goals and Current Realities
Early SLE Disease Control: Targeting IFN Pathway at EULAR 2026
Early ILD Recognition in SARD/SSc: Drivers of Progression and Workflow Solutions
TACE + Camrelizumab/Rivoceranib Improves OS in Unresectable HCC
CAR T-Cell Therapy Guidelines Evolve for Lymphoma, Myeloma at EHA 2026
JASCAYD® (nerandomilast) Offers New Therapeutic Option for COPD
Early Intervention in SLE/LN Reduces Long-Term Damage
ASCO 2026 June 1st Program Highlights: Novel Immunotherapy Data
GLP-1 RAs Reduce CV Risk in T2D Via Weight, Glucose Pathways
CAR T: Speed and Reliability Critical for Patient Outcomes
Few Pediatric Cancer Drugs Reach Phase 3 or Approval
MLVs: Dual Role in Brain Metastases Offers Therapeutic Targets
Infection Prevention Critical in Hematological Malignancies
AATD: Aiming for AAT Restoration and Clinically Meaningful Endpoints
EASL 2026 Forum: Enhancing Patient-Clinician Communication
Rapid SLE Control Prevents Organ Damage: EULAR 2026 Focus
CELMoDs Show Promise in Relapsed/Refractory Multiple Myeloma
Eosinophilic Disorders: Best Practices for HES and EGPA at ATS 2026
Optimizing Frontline LR-MDS Treatment: EHA 2026 Data Review
ASCO 2026 May 30th Program Highlights: Immunotherapy Advances in Solid Tumors
Radiopharmaceutical Therapy: Improving Effectiveness, Access, and Safety
Hypothyroidism: Symptom Burden Persists Despite Euthyroidism
CAR T Cell Therapy Shows Promise in SLE and SSc Immune Reset
AI Algorithms Enhance Pulmonary Disease Management at ATS 2026
Contagion: Acute Respiratory Failure Cases Highlight Ventilator Management
Desmopressin Dosing Refined for Central Diabetes Insipidus
Multidisciplinary Care Improves Spondyloarthritis Outcomes
FLT3 Inhibitors Improve AML Outcomes Pre- and Post-Transplant
Triple Therapy Optimises COPD Outcomes at ATS 2026
Ventilator Management: Foundations for Bedside Implementation
EULAR 2026: Methotrexate Remains Cornerstone in RA First-Line
Multiple Myeloma: Aligning Innovation with Clinical Practice at EHA 2026
Tile Radiation for Large Brain Mets: A New Approach at ASCO 2026
HTAN Decodes Tumor Evolution: Ecological Perspective at AACR2026
Early AxSpA Diagnosis: Case-Based Discussion at EULAR 2026
Lupus Management: Progress and Persistent Challenges at EULAR 2026
CD19+ B-Cell Targeting Shows Efficacy in IgG4-RD Management
CLL First-Line Treatment: BTK Inhibitors vs. Venetoclax Combinations
ASCO 2026: Anticipating Advances in Oncology Treatment
AML: Fitness, Not Age, Predicts IC Eligibility at EHA 2026
Triple Therapy in Asthma: Real-World Evidence Supports Earlier Use
Subcutaneous Immunotherapy Offers Alternative Administration at ASCO 2026
ASCO 2026 May 29th Program Highlights: Novel Oncology Therapies
ATS 2026: Bronchiectasis and NTM Pulmonary Disease Management
RA Treatment Optimisation: Applying Two Decades of Progress
Cancer Therapies Induce Lifespan Comorbidities: ACCR 2026 Review
AML Treatment Strategies: Optimising Outcomes in a Complex Disease
Tafasitamab-R-CHOP Boosts Frontline DLBCL Outcomes at ASCO 2026
Novel Approaches Address Multiple Myeloma Resistance at EHA 2026
IPF/PPF: Patient and Pulmonologist Perspectives Highlight Care Gaps
ANCA Vasculitis: Evolving Strategies Target Remission & Relapse Prevention
Optimising PsA and axSpA Treatment: EULAR 2026 Focuses on Early Intervention
Variceal Bleeding Management: EASL 2026 Skills Centre Focuses on Endoscopic and Pharmacological Strategies
AML: Rethinking Intensive Therapy for Myelodysplasia-Related & Therapy-Related Subtypes
New Biologic Offers Option for Severe Eosinophilic Asthma
CPET Advances Refine Cardiopulmonary Disease Assessment at ATS 2026
Sarcoidosis: Current Understanding of Diagnosis and Management
CLL: Aligning Patient Priorities with Targeted Therapy at EHA 2026
EULAR 2026: Psoriatic Disease Spectrum Highlights
EULAR 2026: Polymyalgia Rheumatica Guidelines Incorporate RWE
Early Breast Cancer at ASCO 2026: Trials to Watch
Novel Therapies Improve Outcomes Post-cBTKi in CLL at EHA 2026
BTK Inhibitors in CLL: Evolving Landscape and Sequential Strategies
Allogeneic Cell Therapy for EBV+ PTLD: EHA 2026 Insights
Liver-Directed Treatment Shows Efficacy in Metabolic Dysfunction
EASL 2026 Consensus: AATD-Liver Disease Management Standardised
Avapritinib Improves Outcomes in Nonadvanced and Advanced Systemic Mastocytosis
Low Alkaline Phosphatase: Recognizing Clinical Consequences
Myriad's Precise MRD™ Test Shows Ultra-Sensitive Detection at ASCO 2026
AIRSUPRA® Reduces Asthma Exacerbations in ATS 2026 Data
EGPA: Early Recognition & Targeted Intervention Improve Outcomes
ATS 2026: Addressing the Cough Assessment Gap in Respiratory Disease
MASH Advanced Fibrosis: Experts Detail Unique Challenges at EASL 2026
Inflammation Drives Sickle Cell Disease Pathophysiology
EASL 2026: Alcohol Policy Action Needed for Liver Disease
Severe Asthma: Beyond Airway Focus in Treatment Decisions at ATS 2026
MASLD Diagnosis Faces Barriers Despite 2024 EASL Guidelines
DLBCL Relapse: EHA 2026 Addresses Gaps in Treatment Strategy
VEXAS Syndrome: Expert Consensus on Multidisciplinary Care at EULAR 2026
Desiccated Thyroid Extract: Efficacy and Safety in Hypothyroidism
IL-33's Dual Role in COPD: Inflammation and Mucus Dysfunction
NDMM Treatment Optimisation: Communication Key to Individualisation
Bispecific Antibodies in FL: EHA 2026 Explores Advancing Outcomes
Real-World Data Confirms Proximal Complement Inhibition in PNH
Outsmarting Shape-Shifting Lung Cancer Resistance
Belantamab Mafodotin's Evolving Role in RRMM: EHA 2026 Insights
Epithelial Cytokines Link Severe Asthma, CRSwNP, COPD at ATS 2026
New 2L+ Combination Therapy Shows Efficacy in RRMM Post-PI/IMiD
Bispecific Antibodies Positioned in Relapsed Follicular Lymphoma
Macrophages: Dual Role in Haematological Malignancies Explored
Doctor-Patient Communication Improves Treatment Acceptance in Cancer
Epithelial Dysfunction: A Unified Target in Airway Disease Management
YUTREPIA® (treprostinil) Inhalation Powder for PH-ILD Patients
CD38 mAb Quad Therapy: Subcutaneous Dosing Reduces Burden
Acute Respiratory Failure: Lifespan Phenotypes and Trajectories
AI Integration Improves Lung Cancer MDT Workflow at ATS 2026
AAT Protein's Role in Lung Health Beyond COPD & Severe Asthma
Symptom Science Integration Improves Cancer Outcomes at ASCO 2026
EASL Congress 2026: Key Trials to Watch in Liver Disease Management
CML Survivorship: Beyond Survival to Quality of Life
JAK Inhibitor Combinations Show Efficacy in Myelofibrosis at EHA 2026
CD20-Targeted Therapies Remain Central to NHL Management
Evolving Infection Prevention in HSCT and Cellular Therapies
Immune Drivers in Autoimmune Cytopenias Inform Patient Care
Pediatric Advanced Bronchoscopy: Precision in Airway Management
A-TANGO Score Refines ACLF Diagnosis, Prognosis in Cirrhosis
EHA 2026: Anticipating Advances in Haematological Malignancies
Systemic Sclerosis: EULAR 2026 Highlights Diagnosis, Prognosis
MASH Diagnosis: Non-Invasive Markers Show Promise at EASL 2026
How Immunotherapy Unmasks Invisible Lung Cancer
B-Cell Dysregulation Targeted Upstream in Primary Sjögren Disease
Acromegaly Management: Focus on Biochemical Control at ENDO 2026
More Breast Cancer Patients Can Skip Axillary Dissection
RA Patients Face Elevated Fracture Risk: EULAR 2026 Highlights
Molecular Hematology: From Gene Profiles to Therapy Profiles at EHA 2026
Endo 2026: Risk-Based Osteoporosis Management Refines Clinical Practice
Steroidogenesis Inhibitor Targets Root Cause of Cushing’s Syndrome
Cushing's Syndrome: Addressing Diagnostic Delays and Treatment Gaps
BCMA-Directed Therapies Show Efficacy in Relapsed/Refractory Multiple Myeloma
FLT3mut+ AML Outcomes: EHA 2026 Reviews Current Strategies
Sjögren’s Disease: Targeting Underlying Activity Beyond Symptoms
MRD Status Guides First-Line Treatment Duration in Haematologic Malignancies
Peer Insights on Once-Daily Weight Management Therapy at endo 2026
TRUQAP + Fulvestrant: 2L Option for HR+/HER2- aBC/mBC with PI3K-AKT Alterations
XLH Management: Rheumatology Must Adapt at EULAR 2026
EASL 2026: Non-invasive Diagnostics Advance Liver Disease Staging
Hypoparathyroidism Treatment: Patient, Care Partner, HCP Perspectives
AI Foundation Models Enhance Diagnostic Insights in Oncology
CAR T in DLBCL: Optimising Patient Outcomes at EHA 2026
Bronchoscopy Training: ATS 2026 Focuses on EBUS and Guided Techniques
EULAR 2026: Earlier AxSpA Recognition Improves Disease Burden
MAVEs Inform Variant Interpretation in Clinical Oncology Practice
ATS 2026: Ultrasound Education Advances for Clinical Practice
XLH Adults: Osteomalacia Persists Despite Conventional Therapy
SLE Pathophysiology Advances Inform Future Precision Care at EULAR 2026
Severe Hypoglycemia in T1D: Enhancing Patient-Clinician Dialogue
Endocrinologists' Role in Early Thyroid Eye Disease Recognition
Allogeneic Cell Therapy for EBV+ PTLD: EHA 2026 Insights
Immunological Insights Inform ILD & Transplant Outcomes
Immuno-Fibrotic Crosstalk: A New Target in Rheumatology
ICI Dissemination Challenges Highlighted at ASCO 2026
Infection Prevention Critical in Hematological Malignancies
HDV Management: EASL 2026 Highlights PegIFN-α as Standard
Late-Onset Genetic Cholestasis: Underdiagnosis in Adults Examined
DLBCL Treatment: Emerging Targeted Therapies at EHA 2026
AML: Fitness, Not Age, Predicts Intensive Chemotherapy Eligibility
Classic CAH: New Approaches to Glucocorticoid Dosing
DLBCL Treatment Sequencing: EHA 2026 Explores Current Therapies
IKT-001 Adaptive Study Programme for Pulmonary Arterial Hypertension
CLL: EHA 2026 to Address Unmet Needs in Treatment Selection
ILD Diagnosis and Management: A Practical ATS 2026 Update
Myelofibrosis Management: Cytopenia Guides Treatment at EHA 2026
ASCO 2026 May 31st Program Highlights: Focus on Novel Immunotherapies
TLR7/8 Inhibition Offers New Lupus Perspective at EULAR 2026
Personalized Hemophilia Care: EHA 2026 Highlights Individualized Approaches
Multimodal OSA Treatment: Nerve Stimulation, Surgery, Oral Appliances
DLBCL Management: Bispecific Antibodies as Emerging Therapeutic Option
Cancer Care Disparities Highlighted in Crisis, Displaced Populations
Immunotherapy and Targeted Therapy: New Data from ASCO 2026
BCMA Bispecifics Transition to Community Myeloma Care: EHA 2026
Fixed-Duration BCL-2 Combo Offers Time Off Treatment in 1L CLL
Yoga Reduces Insomnia, Fatigue, Anxiety in Cancer Survivors
RA Care: Navigating Treatment Choices at EULAR 2026
Optimising Transplant in Haemoglobinopathies: EHA 2026 Perspectives
ATS 2026: Lung Cancer Management Advances in Targeted Therapy
Novel Biomarkers Improve Pediatric Solid Tumor Detection
Caplacizumab Improves iTTP Outcomes in Real-World Settings
Bispecific Antibodies Show Promise in Relapsed/Refractory Haematological Malignancies
Hypercortisolism: Emerging Diagnostic and Management Insights
CAR T Cell Therapy Shows Efficacy in Autoimmune Diseases at EULAR 2026
Early Intervention Crucial for Inflammatory Joint Disease, Osteoporosis
Chemo-Free Therapy Improves Outcomes in Pediatric APL (EHA 2026)
PEAK Study Shows Novel Agent Improves PFS in Advanced GIST
Treat-to-Target in SLE: Balancing Burden, Benefit, and Risk
CAR T Therapy Shows Sustained Efficacy in Relapsed/Refractory Lymphoma
Next-Gen Extracellular Vesicles: Biomarkers, Targets, Deliverables in Oncology
HYRNUO® (Sevabertinib) Shows Efficacy in Advanced Solid Tumours
AI in Hematology: EHA 2026 Focuses on Practical, Ethical Integration
Korlym® Improves Cushing's Syndrome Symptoms in Patient Experience Data
IDH1m AML: Ivosidenib Plus Azacitidine Improves OS by 12.5 Months
EASL 2026: PSC Therapies Advance Beyond Symptom Management
EASL 2026: Liver and Spleen Elastography for Fibrosis Assessment
Right Heart Catheterization: ATS 2026 Clarifies Waveform Interpretation
Inluriyo™ and Verzenio® Presentations at ASCO 2026
NK Cell Immunotherapy: Biology to Clinic at AACR 2026
ATS 2026: NTM Lung Disease Detection, Therapy, QoL Advancements
HER2-Expressing Breast Cancer: Advancements in Targeted Therapies
Obesity Management Improves Psoriatic Disease Outcomes
CLL First-Line Therapy: Case-Based Insights from EHA 2026
Afirma Molecular Testing: Unique Situations and New Prognostic Development
Oncodetect® MRD Test Shows Analytical Validity, Clinical Utility at ASCO
Salivary Galectin-9 Elevated in Primary Sjögren's, Lacks Disease Activity Correlation
AI, Wearables Transform Sleep Diagnostics: ATS 2026 Preview
Iron Status Clarifies Erythrocytosis, Symptoms in Polycythemia Vera
BRINSUPRI® First Therapy Approved for NCFB at ATS 2026
MCED Tests Show Promise for Earlier Cancer Detection at ASCO 2026
DNA Methylation Patterns Emerge as Sarcoma Biomarkers
Tirzepatide: Efficacy in Weight Management Explored at ATS 2026
Autoantibodies: Hidden Drivers of Autoimmune Rheumatic Diseases
Pediatric Pulmonary Research Gaps Highlighted for Global Health
Novel Approaches in R/R MM: Expert Perspectives from EHA 2026
Defining Hyperphagia Treatment Possibilities in Prader-Willi Syndrome
12 Months of Romosozumab Builds Bone Density in Postmenopausal Osteoporosis
Multidisciplinary Approach Improves Autoimmune ILD Management
Rare Conditions: EHA 2026 Highlights Diagnostic Challenges
SpA Remission: Clinical Symptoms vs. Subclinical Inflammation at EULAR 2026
Bispecific Antibodies Show Promise in Relapsed/Refractory Multiple Myeloma
Bispecific Antibodies Efficacious in Multiple Myeloma with Renal Impairment
Biomarkers and Novel Treatments Highlight Prostate Cancer Advances at ASCO
ITP Management: Bridging Clinician and Patient Perspectives
AI in Oncology: Practical Applications Transforming Cancer Care
Obesity Care: Tailored Treatment Strategies Highlighted at endo 2026
NDMM Treatment Advances: Quadruplet Regimens Show Efficacy
Cancer Elimination at ASCO 2026: Aspirational Goals and Current Realities
Early SLE Disease Control: Targeting IFN Pathway at EULAR 2026
Early ILD Recognition in SARD/SSc: Drivers of Progression and Workflow Solutions
TACE + Camrelizumab/Rivoceranib Improves OS in Unresectable HCC
CAR T-Cell Therapy Guidelines Evolve for Lymphoma, Myeloma at EHA 2026
JASCAYD® (nerandomilast) Offers New Therapeutic Option for COPD
Early Intervention in SLE/LN Reduces Long-Term Damage
ASCO 2026 June 1st Program Highlights: Novel Immunotherapy Data
GLP-1 RAs Reduce CV Risk in T2D Via Weight, Glucose Pathways
CAR T: Speed and Reliability Critical for Patient Outcomes
Few Pediatric Cancer Drugs Reach Phase 3 or Approval
MLVs: Dual Role in Brain Metastases Offers Therapeutic Targets
Infection Prevention Critical in Hematological Malignancies
AATD: Aiming for AAT Restoration and Clinically Meaningful Endpoints
EASL 2026 Forum: Enhancing Patient-Clinician Communication
Rapid SLE Control Prevents Organ Damage: EULAR 2026 Focus
CELMoDs Show Promise in Relapsed/Refractory Multiple Myeloma
Eosinophilic Disorders: Best Practices for HES and EGPA at ATS 2026
Optimizing Frontline LR-MDS Treatment: EHA 2026 Data Review
ASCO 2026 May 30th Program Highlights: Immunotherapy Advances in Solid Tumors
Radiopharmaceutical Therapy: Improving Effectiveness, Access, and Safety
Hypothyroidism: Symptom Burden Persists Despite Euthyroidism
CAR T Cell Therapy Shows Promise in SLE and SSc Immune Reset
AI Algorithms Enhance Pulmonary Disease Management at ATS 2026
Contagion: Acute Respiratory Failure Cases Highlight Ventilator Management
Desmopressin Dosing Refined for Central Diabetes Insipidus
Multidisciplinary Care Improves Spondyloarthritis Outcomes
FLT3 Inhibitors Improve AML Outcomes Pre- and Post-Transplant
Triple Therapy Optimises COPD Outcomes at ATS 2026
Ventilator Management: Foundations for Bedside Implementation
EULAR 2026: Methotrexate Remains Cornerstone in RA First-Line
Multiple Myeloma: Aligning Innovation with Clinical Practice at EHA 2026
Tile Radiation for Large Brain Mets: A New Approach at ASCO 2026
HTAN Decodes Tumor Evolution: Ecological Perspective at AACR2026
Early AxSpA Diagnosis: Case-Based Discussion at EULAR 2026
Lupus Management: Progress and Persistent Challenges at EULAR 2026
CD19+ B-Cell Targeting Shows Efficacy in IgG4-RD Management
CLL First-Line Treatment: BTK Inhibitors vs. Venetoclax Combinations
ASCO 2026: Anticipating Advances in Oncology Treatment
AML: Fitness, Not Age, Predicts IC Eligibility at EHA 2026
Triple Therapy in Asthma: Real-World Evidence Supports Earlier Use
Subcutaneous Immunotherapy Offers Alternative Administration at ASCO 2026
ASCO 2026 May 29th Program Highlights: Novel Oncology Therapies
ATS 2026: Bronchiectasis and NTM Pulmonary Disease Management
RA Treatment Optimisation: Applying Two Decades of Progress
Cancer Therapies Induce Lifespan Comorbidities: ACCR 2026 Review
AML Treatment Strategies: Optimising Outcomes in a Complex Disease
Tafasitamab-R-CHOP Boosts Frontline DLBCL Outcomes at ASCO 2026
Novel Approaches Address Multiple Myeloma Resistance at EHA 2026
IPF/PPF: Patient and Pulmonologist Perspectives Highlight Care Gaps
ANCA Vasculitis: Evolving Strategies Target Remission & Relapse Prevention
Optimising PsA and axSpA Treatment: EULAR 2026 Focuses on Early Intervention
Variceal Bleeding Management: EASL 2026 Skills Centre Focuses on Endoscopic and Pharmacological Strategies
AML: Rethinking Intensive Therapy for Myelodysplasia-Related & Therapy-Related Subtypes
New Biologic Offers Option for Severe Eosinophilic Asthma
CPET Advances Refine Cardiopulmonary Disease Assessment at ATS 2026
Sarcoidosis: Current Understanding of Diagnosis and Management
CLL: Aligning Patient Priorities with Targeted Therapy at EHA 2026
EULAR 2026: Psoriatic Disease Spectrum Highlights
EULAR 2026: Polymyalgia Rheumatica Guidelines Incorporate RWE
Early Breast Cancer at ASCO 2026: Trials to Watch
Novel Therapies Improve Outcomes Post-cBTKi in CLL at EHA 2026
BTK Inhibitors in CLL: Evolving Landscape and Sequential Strategies
Allogeneic Cell Therapy for EBV+ PTLD: EHA 2026 Insights
Liver-Directed Treatment Shows Efficacy in Metabolic Dysfunction
EASL 2026 Consensus: AATD-Liver Disease Management Standardised
Avapritinib Improves Outcomes in Nonadvanced and Advanced Systemic Mastocytosis
Low Alkaline Phosphatase: Recognizing Clinical Consequences
Myriad's Precise MRD™ Test Shows Ultra-Sensitive Detection at ASCO 2026
AIRSUPRA® Reduces Asthma Exacerbations in ATS 2026 Data
EGPA: Early Recognition & Targeted Intervention Improve Outcomes
ATS 2026: Addressing the Cough Assessment Gap in Respiratory Disease
MASH Advanced Fibrosis: Experts Detail Unique Challenges at EASL 2026
Inflammation Drives Sickle Cell Disease Pathophysiology
EASL 2026: Alcohol Policy Action Needed for Liver Disease
Severe Asthma: Beyond Airway Focus in Treatment Decisions at ATS 2026
MASLD Diagnosis Faces Barriers Despite 2024 EASL Guidelines
DLBCL Relapse: EHA 2026 Addresses Gaps in Treatment Strategy
VEXAS Syndrome: Expert Consensus on Multidisciplinary Care at EULAR 2026
Desiccated Thyroid Extract: Efficacy and Safety in Hypothyroidism
IL-33's Dual Role in COPD: Inflammation and Mucus Dysfunction
NDMM Treatment Optimisation: Communication Key to Individualisation
Bispecific Antibodies in FL: EHA 2026 Explores Advancing Outcomes
Real-World Data Confirms Proximal Complement Inhibition in PNH
Outsmarting Shape-Shifting Lung Cancer Resistance
Belantamab Mafodotin's Evolving Role in RRMM: EHA 2026 Insights
Epithelial Cytokines Link Severe Asthma, CRSwNP, COPD at ATS 2026
New 2L+ Combination Therapy Shows Efficacy in RRMM Post-PI/IMiD
Bispecific Antibodies Positioned in Relapsed Follicular Lymphoma
Macrophages: Dual Role in Haematological Malignancies Explored
Doctor-Patient Communication Improves Treatment Acceptance in Cancer
Epithelial Dysfunction: A Unified Target in Airway Disease Management
YUTREPIA® (treprostinil) Inhalation Powder for PH-ILD Patients
CD38 mAb Quad Therapy: Subcutaneous Dosing Reduces Burden
Acute Respiratory Failure: Lifespan Phenotypes and Trajectories
AI Integration Improves Lung Cancer MDT Workflow at ATS 2026
AAT Protein's Role in Lung Health Beyond COPD & Severe Asthma
Symptom Science Integration Improves Cancer Outcomes at ASCO 2026
EASL Congress 2026: Key Trials to Watch in Liver Disease Management
CML Survivorship: Beyond Survival to Quality of Life
JAK Inhibitor Combinations Show Efficacy in Myelofibrosis at EHA 2026
CD20-Targeted Therapies Remain Central to NHL Management
Evolving Infection Prevention in HSCT and Cellular Therapies
Immune Drivers in Autoimmune Cytopenias Inform Patient Care
Pediatric Advanced Bronchoscopy: Precision in Airway Management
A-TANGO Score Refines ACLF Diagnosis, Prognosis in Cirrhosis
EHA 2026: Anticipating Advances in Haematological Malignancies
Systemic Sclerosis: EULAR 2026 Highlights Diagnosis, Prognosis
MASH Diagnosis: Non-Invasive Markers Show Promise at EASL 2026
How Immunotherapy Unmasks Invisible Lung Cancer
B-Cell Dysregulation Targeted Upstream in Primary Sjögren Disease
Acromegaly Management: Focus on Biochemical Control at ENDO 2026
More Breast Cancer Patients Can Skip Axillary Dissection
RA Patients Face Elevated Fracture Risk: EULAR 2026 Highlights
Molecular Hematology: From Gene Profiles to Therapy Profiles at EHA 2026
Endo 2026: Risk-Based Osteoporosis Management Refines Clinical Practice
Steroidogenesis Inhibitor Targets Root Cause of Cushing’s Syndrome
Cushing's Syndrome: Addressing Diagnostic Delays and Treatment Gaps
BCMA-Directed Therapies Show Efficacy in Relapsed/Refractory Multiple Myeloma
FLT3mut+ AML Outcomes: EHA 2026 Reviews Current Strategies
Sjögren’s Disease: Targeting Underlying Activity Beyond Symptoms
MRD Status Guides First-Line Treatment Duration in Haematologic Malignancies
Peer Insights on Once-Daily Weight Management Therapy at endo 2026
TRUQAP + Fulvestrant: 2L Option for HR+/HER2- aBC/mBC with PI3K-AKT Alterations
XLH Management: Rheumatology Must Adapt at EULAR 2026
EASL 2026: Non-invasive Diagnostics Advance Liver Disease Staging
Hypoparathyroidism Treatment: Patient, Care Partner, HCP Perspectives
AI Foundation Models Enhance Diagnostic Insights in Oncology
CAR T in DLBCL: Optimising Patient Outcomes at EHA 2026
Bronchoscopy Training: ATS 2026 Focuses on EBUS and Guided Techniques
EULAR 2026: Earlier AxSpA Recognition Improves Disease Burden
MAVEs Inform Variant Interpretation in Clinical Oncology Practice
ATS 2026: Ultrasound Education Advances for Clinical Practice
XLH Adults: Osteomalacia Persists Despite Conventional Therapy
SLE Pathophysiology Advances Inform Future Precision Care at EULAR 2026
Severe Hypoglycemia in T1D: Enhancing Patient-Clinician Dialogue
Endocrinologists' Role in Early Thyroid Eye Disease Recognition
Allogeneic Cell Therapy for EBV+ PTLD: EHA 2026 Insights
Immunological Insights Inform ILD & Transplant Outcomes
Immuno-Fibrotic Crosstalk: A New Target in Rheumatology
ICI Dissemination Challenges Highlighted at ASCO 2026
Infection Prevention Critical in Hematological Malignancies
HDV Management: EASL 2026 Highlights PegIFN-α as Standard
